Pharmacyte Biotech Inc (PMCB) Stock Price, Quote & News

Company Profile

PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other soli...

Industry: Biotechnology

Sector: Healthcare

Phone: 917-595-2850

Fax: 917-595-2851

Website: pharmacyte.com

Address:

3960 Howard Hughes Parkway, Suite 500, Las Vegas, United States

yl_trader Sep. 8 at 7:08 PM

$PMCB looks like it wants to go

0 · Reply

JJBurch Sep. 8 at 5:29 PM

$TNFA I’m busy today but I’ll give one final warning. Get into TNFA as quickly as possible $PMCB is your clue $OPEN $PLTR $XBI

1 · Reply

SevenMoons Sep. 8 at 5:06 PM

$PMCB pushing pretty decent

0 · Reply

JJBurch Sep. 8 at 3:47 PM

$TNFA $IXHL WHAT DID I TWLL YOU???? Congrats to all!!!!! Just the start. $OPEN $PLTR $PMCB $TNFA

0 · Reply

OTC85 Sep. 8 at 3:32 PM

$PMCB $EDGM

0 · Reply

JJBurch Sep. 8 at 3:29 PM

$PMCB 🚨 🚨 🚨 KEEP YOUR EYES ON PMCB FOR POSSIBLE BIG DEAL WITH $TNFA INCLUDING POSSIBLE PURCHASE OF BIO ASSETS $TNFA CHANGING BUSINESS AND NAME THIS WEEK PRESENTING BRAND NEW DECK ON WEDNESDAY IN PREMARKET AND THEY HAVE A TON TO REVEAL!! AND WILL! TNFA goes up several 100% THIS WEEK!! Hurry and do your DD I mean like right now. $OPEN $IXHL $PLTR

0 · Reply

NVDAMillionaire Sep. 5 at 8:18 PM

$PMCB Really good write-up that perfectly summarizes PMCB's present situation. So if you want to bring your PMCB knowledge up to date or just discover PMCB, this is required reading. https://beyondspx.com/quote/PMCB/pharmacyte-biotech-s-high-stakes-pursuit-unlocking-value-through-encapsulation-technology-and-clinical-breakthroughs-nasdaq-pmcb#analysis

0 · Reply

JJBurch Sep. 4 at 2:12 PM

$TNFA $NVDA $OPEN $PMCB This pressure cooker is going to FLY IMMINENTLY it’s so obvious There are NO SHARES available to trade The ability to cover the shorts is gone SQUEEZE!!!!!!!!

0 · Reply

JJBurch Sep. 4 at 2:02 PM

$TNFA $4+ today is GUARANTEED $5++ is HIGHLY LIKELY today Next week with all of the news on the new company, name, business, CEO, and licensing deal with $PMCB I absolutely see $TNFA easily going above $20 Possibly $25++ This next couple of weeks are going to be EPIC!!!!!! Follow me; join me; let’s make the money people. I mean it sincerely. This is our time right here right now $OPEN $LLY $NVDA Congratulations. !!!!

0 · Reply

JJBurch Sep. 4 at 1:20 PM

$TNFA T the very least $PMCB will license their assets and take them to the finish line “We are actively engaging strategic opportunities to continue the development of isomyosamine and Supera-CBD,” said Mitchell Glass, Chief Medical Officer. “Our goal is to ensure these assets continue to create value for shareholders.” This thing will go above $50 a share in 2025 We shall revisit this post!

0 · Reply

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

TNFA

Aug 20, 2025, 9:15 AM EDT - 19 days ago

PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing

Aug 18, 2025, 9:15 AM EDT - 21 days ago

PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

May 21, 2024, 9:00 AM EDT - 1 year ago

MyMD Pharmaceuticals Secures Strategic Investments

May 21, 2024, 9:00 AM EDT - 1 year ago

PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease

Nov 15, 2023, 8:30 AM EST - 1 year ago

PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc.

FEMY

Oct 31, 2023, 9:15 AM EDT - 2 years ago

PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology

Jun 15, 2023, 9:15 AM EDT - 2 years ago

PharmaCyte Biotech Announces Final Results of Tender Offer

May 11, 2023, 8:30 AM EDT - 2 years ago

PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share

Feb 2, 2023, 9:00 AM EST - 2 years ago

PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan

Oct 7, 2022, 9:00 AM EDT - 3 years ago

PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value

Aug 15, 2022, 8:30 AM EDT - 3 years ago

PharmaCyte Biotech Reaches Cooperation Agreement with Iroquois Capital

Jul 28, 2022, 12:49 PM EDT - 3 years ago

PharmaCyte Biotech Rebukes Iroquois' Commencement of Consent Solicitation

Jul 28, 2022, 9:00 AM EDT - 3 years ago

Iroquois Files Preliminary Consent Materials to Reconstitute Board of Directors at PharmaCyte Biotech, Inc.

Jul 21, 2022, 8:30 AM EDT - 3 years ago

PharmaCyte Biotech Commences First Phase of Two-Phase Pig Study

Jul 19, 2022, 8:30 AM EDT - 3 years ago

PharmaCyte Biotech Reports Positive Interim Results in Malignant Ascites Mouse Model Study

Jul 11, 2022, 8:30 AM EDT - 3 years ago

PharmaCyte Biotech Announces Preliminary Unaudited Financial Results for Fiscal Year 2022

Jul 11, 2022, 6:00 AM EDT - 3 years ago

IROQUOIS CAPITAL COMMENCES CONSENT SOLICITATION TO RECONSTITUTE PHARMACYTE BIOTECH BOARD OF DIRECTORS

Jul 5, 2022, 3:16 PM EDT - 3 years ago

IROQUOIS CAPITAL ISSUES STATEMENT IN RESPONSE TO RECENT ACTIONS BY THE PHARMACYTE BIOTECH BOARD OF DIRECTORS

Jul 5, 2022, 8:30 AM EDT - 3 years ago

PharmaCyte Biotech Announces Additional Quality Control Assay and Confirms Stability of CypCap Cells

Jun 23, 2022, 9:00 AM EDT - 3 years ago

IROQUOIS CAPITAL NOMINATES SLATE OF HIGHLY QUALIFIED DIRECTOR CANDIDATES FOR ELECTION AT PHARMACYTE'S 2022 ANNUAL MEETING

Jun 15, 2022, 8:30 AM EDT - 3 years ago

PharmaCyte Biotech Issues Follow-Up Response to Iroquois Capital's Second Letter on June 9 and Reiterates Commitment to Increasing Shareholder Value

Jun 13, 2022, 8:30 AM EDT - 3 years ago

PharmaCyte Biotech to Attend 2022 BIO International Convention in San Diego

Jun 9, 2022, 9:00 AM EDT - 3 years ago

IROQUOIS CAPITAL DELIVERS OPEN LETTER TO PHARMACYTE BIOTECH BOARD OF DIRECTORS

Jun 8, 2022, 8:30 AM EDT - 3 years ago

PharmaCyte Biotech Issues Response to Iroquois Capital Letter and Announces Additional Steps to Increase Shareholder Value

Jun 2, 2022, 9:00 AM EDT - 3 years ago

PharmaCyte Biotech to Implement $10-Million Share Repurchase Program

May 23, 2022, 9:00 AM EDT - 3 years ago

PharmaCyte Biotech Initiates Studies to Confirm Its Pancreatic Cancer Therapy Can Treat Malignant Ascites

May 11, 2022, 9:00 AM EDT - 3 years ago

Iroquois Capital Delivers Open Letter to PharmaCyte Biotech Board of Directors

Apr 27, 2022, 9:00 AM EDT - 3 years ago

PharmaCyte Biotech to Attend 15th International Conference on Advanced Technologies and Treatments for Diabetes

Apr 19, 2022, 9:00 AM EDT - 3 years ago

PharmaCyte Biotech Announces More Positive Tests Results for Its Pancreatic Cancer Clinical Trial Product Candidate to Satisfy FDA Requirements

Apr 13, 2022, 9:00 AM EDT - 3 years ago

PharmaCyte Biotech to Accelerate Preparations for Start of Pancreatic Cancer Clinical Trial

Apr 5, 2022, 9:00 AM EDT - 3 years ago

PharmaCyte Biotech Appoints Dr. Matthias Löhr to Board of Directors

Mar 22, 2022, 9:00 AM EDT - 3 years ago

PharmaCyte Biotech Successfully Completes 24-Month Stability Study of Its Clinical Trial Product Candidate

Mar 16, 2022, 9:00 AM EDT - 3 years ago

PharmaCyte Biotech Reports Third Quarter Financial Results and Operational Highlights

Feb 22, 2022, 9:00 AM EST - 3 years ago

PharmaCyte Biotech Announces Genetic Stability of Cytochrome P450 Gene and Site of Integration

Feb 14, 2022, 9:00 AM EST - 3 years ago

PharmaCyte Biotech Updates Status of Investigational New Drug Application to FDA

Jan 7, 2022, 2:59 AM EST - 3 years ago

Is This A Good Time To Invest In PharmaCyte?

Jan 6, 2022, 9:00 AM EST - 3 years ago

PharmaCyte Biotech to Present at H.C. Wainwright BioConnect Conference

Jan 4, 2022, 9:00 AM EST - 3 years ago

PharmaCyte Biotech Study Proves Capsule Material Is Not Toxic For Encapsulated Cells

Dec 28, 2021, 9:00 AM EST - 4 years ago

PharmaCyte Biotech Successfully Completes 36 Month Master Cell Bank Stability Study

Dec 15, 2021, 9:00 AM EST - 4 years ago

PharmaCyte Biotech Reports Second Quarter 2021 Financial Results and Operational Highlights

Dec 8, 2021, 10:16 AM EST - 4 years ago

PharmaCyte Biotech Successfully Completes Cytochrome P450 Site of Integration DNA Sequencing Assay

Nov 30, 2021, 1:05 AM EST - 4 years ago

PharmaCyte Biotech Launches Malignant Ascites Program with Commencement of Pivotal Preclinical Study

Nov 12, 2021, 9:00 AM EST - 4 years ago

PharmaCyte Biotech Announces Cell Encapsulation Technology Material Does Not Cause Skin Irritation

Sep 27, 2021, 9:00 AM EDT - 4 years ago

PharmaCyte Biotech Announces Encapsulation Material Does Not Alter Cellular DNA

Sep 21, 2021, 9:00 AM EDT - 4 years ago

PharmaCyte Biotech Releases More Positive Results From FDA-Required Biocompatibility Tests

Sep 16, 2021, 1:51 PM EDT - 4 years ago

Why Are PharmaCyte Shares Moving Higher On Thursday?

Sep 16, 2021, 9:00 AM EDT - 4 years ago

PharmaCyte Biotech Announces Positive Results of Biocompatibility Study for FDA

Sep 9, 2021, 8:57 AM EDT - 4 years ago

Why Is PharmaCyte Biotech Stock Moving Higher In Premarket Thursday?

Sep 8, 2021, 9:00 AM EDT - 4 years ago

PharmaCyte Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

yl_trader Sep. 8 at 7:08 PM

$PMCB looks like it wants to go

0 · Reply

JJBurch Sep. 8 at 5:29 PM

$TNFA I’m busy today but I’ll give one final warning. Get into TNFA as quickly as possible $PMCB is your clue $OPEN $PLTR $XBI

1 · Reply

SevenMoons Sep. 8 at 5:06 PM

$PMCB pushing pretty decent

0 · Reply

JJBurch Sep. 8 at 3:47 PM

$TNFA $IXHL WHAT DID I TWLL YOU???? Congrats to all!!!!! Just the start. $OPEN $PLTR $PMCB $TNFA

0 · Reply

OTC85 Sep. 8 at 3:32 PM

$PMCB $EDGM

0 · Reply

JJBurch Sep. 8 at 3:29 PM

0 · Reply

NVDAMillionaire Sep. 5 at 8:18 PM

0 · Reply

JJBurch Sep. 4 at 2:12 PM

$TNFA $NVDA $OPEN $PMCB This pressure cooker is going to FLY IMMINENTLY it’s so obvious There are NO SHARES available to trade The ability to cover the shorts is gone SQUEEZE!!!!!!!!

0 · Reply

JJBurch Sep. 4 at 2:02 PM

0 · Reply

JJBurch Sep. 4 at 1:20 PM

0 · Reply

ACInvestorBlog Sep. 2 at 1:38 PM

$PMCB $TNFA PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications https://www.streetinsider.com/Corporate+News/PharmaCyte+increases+TNF+Pharmaceuticals+stake+by+%243+million/25282449.html PharmaCyte increases TNF Pharmaceuticals stake by $3 million

0 · Reply

JJBurch Sep. 2 at 1:30 PM

$TNFA I told you $PMCB took a larger stake Man Nailed this one With a crypto business changing surprise. Let’s fly

1 · Reply

DonCorleone77 Sep. 2 at 1:28 PM

$TNFA $PMCB -- TNF Pharmaceuticals announces $7M private placement -- PharmaCyte Biotech increases stake in TNF Pharmaceuticals by $3M

0 · Reply

SevenMoons Aug. 26 at 4:36 PM

$PMCB who keeps raising the bids on calls and messing with it lol 😂

0 · Reply

JJBurch Aug. 26 at 10:32 AM

$PMCB is this company doubling down n its investment of $FEMY with the newest offering? They have a board seat. They’ve lost 75% of their initial investment Still think PMCB is going to have to make a buyout offer to either or BOTH of $FEMY and $TNFA very quickly

3 · Reply

CCTVon Aug. 26 at 12:22 AM

$PMCB acquiring $TNFA and just got 7m. Wonder what they're gonna do with it? 💥 Glad I'm in this!!

1 · Reply

JJBurch Aug. 25 at 4:24 PM

$TNFA News likely no LATER than this Wednesday My educated guess is some bulked up relationship with $PMCB to begin. Could be an outright buyout or preferred equity raise Ph2 results Nasdaq extension Folks…it will be one thing after another leading to buyback of shares and everything lining up to mimic my other big win at $IXHL Enjoy it folks. $OPEN $XBI

3 · Reply

JJBurch Aug. 25 at 3:20 PM

$PMCB raised $7M; didn’t need it; except to invest more in $TNFA Watch the announcement this week Preferred buy Possible buyout It’s ALL GOOD ahead. Mean this sincerely Let’s fucking do this thing!!! $IXHL $OPEN ❤️

0 · Reply

JJBurch Aug. 25 at 1:15 PM

$TNFA Ph2b coming and it will be positive. But BEFORE that; either a buyout or $PMCB makes a preferred stock equity investment here Something MASSIVE will be announced this week Then, hold…for positive Ph2b This is such an unbelievable opportunity from anywhere down here at the bottom Wow I mean WOW SINCERELY.

1 · Reply

JJBurch Aug. 22 at 3:16 PM

$PMCB buyout of $TNFA Announcement early next week

5 · Reply

DJORCKO Aug. 22 at 3:04 PM

$PMCB my average 1.03 . Im patient here

0 · Reply

PatrickTrades2 Aug. 21 at 3:50 PM

$LLY $PMCB $TNFA $VKTX $XBI how are this many people following this fraud?

1 · Reply

Market Cap	6.40M
Revenue (ttm)	0.00
Net Income (ttm)	30.66M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	533,200
Avg Vol	63,086
Day's Range	N/A - N/A
Shares Out	6.80M
Stochastic %K	15%
Beta	-0.24
Analysts	Strong Buy
Price Target	N/A